Mark A Dickson Selected Research

Mark A Dickson Research Topics

Disease

28	Neoplasms (Cancer) 01/2024 - 12/2009
24	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 05/2012
9	Liposarcoma 09/2023 - 06/2013
5	Melanoma (Melanoma, Malignant) 01/2023 - 06/2013
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 06/2017
4	Leiomyosarcoma 01/2019 - 09/2014
3	Perivascular Epithelioid Cell Neoplasms 03/2024 - 04/2013
3	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2023 - 01/2018
3	Hemangiosarcoma (Angiosarcoma) 01/2022 - 09/2014
3	Anemia 01/2022 - 01/2019
3	Exanthema (Rash) 01/2022 - 04/2016
3	Fatigue 01/2022 - 04/2011
3	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2014
2	Hypersensitivity (Allergy) 10/2023 - 01/2017
2	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2020
2	Hypophosphatemia 01/2022 - 01/2022
2	Nausea 01/2022 - 12/2009
2	Edema (Dropsy) 01/2022 - 01/2019
2	Neutropenia 01/2020 - 12/2009
2	Dermatofibrosarcoma 01/2019 - 04/2017
2	Lymphoma (Lymphomas) 09/2014 - 01/2014
2	Hyponatremia 04/2011 - 12/2009
1	Arthralgia (Joint Pain) 10/2023
1	Hypothyroidism 10/2023
1	Pneumonia (Pneumonitis) 10/2023
1	Blister (Bulla) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Pain (Aches) 01/2023
1	Weight Loss (Weight Reduction) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	AIDS-related Kaposi sarcoma 01/2020
1	Neurofibrosarcoma (MPNST) 01/2019
1	Fever (Fevers) 01/2019
1	Hyperphosphatemia 01/2019
1	Myocardial Infarction 01/2019
1	Synovial Sarcoma (Synovioma) 01/2019

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 10/2023 - 01/2015
5	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2019
4	IpilimumabIBA 06/2017 - 06/2013
3	Sirolimus (Rapamycin)FDA Link 03/2024 - 04/2013
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2022
3	RNA (Ribonucleic Acid)IBA 10/2023 - 06/2015
3	Docetaxel (Taxotere)FDA Link 10/2023 - 01/2015
3	binimetinibIBA 01/2022 - 10/2019
3	palbociclibIBA 01/2020 - 06/2013
3	alvocidib (flavopiridol)IBA 05/2012 - 12/2009
2	pembrolizumabIBA 01/2023 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2012
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2019
2	selinexorIBA 01/2022 - 10/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2010
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 11/2015
2	Retinoblastoma ProteinIBA 01/2020 - 04/2017
2	B7-H1 AntigenIBA 01/2020 - 03/2015
2	mocetinostatIBA 01/2019 - 01/2018
1	Transaminases (Aminotransferases)IBA 10/2023
1	olaratumabIBA 10/2023
1	abemaciclibIBA 09/2023
1	indoleIBA 01/2023
1	Imiquimod (Aldara)FDA LinkGeneric 01/2023
1	DioxygenasesIBA 01/2023
1	epacadostatIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 01/2022
1	HhAntag691IBA 01/2022
1	bempegaldesleukinIBA 01/2022
1	CreatinineIBA 01/2022
1	NivolumabIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	MART-1 AntigenIBA 01/2022
1	Cathepsin KIBA 01/2022
1	Protons (Proton)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	talimogene laherparepvecIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	pexidartinibIBA 10/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	infigratinibIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2018
1	Proto-Oncogene Proteins c-mdm2IBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 06/2017

Therapy/Procedure

22	Therapeutics 10/2023 - 06/2013
7	Drug Therapy (Chemotherapy) 01/2023 - 04/2013
3	Radiotherapy 10/2023 - 01/2021
2	Immunotherapy 01/2023 - 01/2019
2	Stem Cell Transplantation 01/2018 - 01/2014
1	Cryotherapy (Therapy, Cold) 01/2023
1	Proton Therapy 01/2021
1	Drug Tapering 01/2019